X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-31 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.11 | -125,000 | 3,500,000 | -3% | -$4,263,915 | |||||
2023-05-12 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $33.84 | -25,000 | 3,625,000 | -1% | -$846,000 | ||||||
| M | 2023-05-08 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.30 | -250,000 | 3,650,000 | -6% | -$8,575,030 | |||||
2023-04-20 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $29.12 | -200,000 | 3,900,000 | -5% | -$5,823,760 | ||||||
| A | 2023-03-31 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $31.25 | -200,000 | 4,100,000 | -5% | -$6,250,000 | |||||
2023-03-31 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $31.25 | -200,000 | 4,100,000 | -5% | -$6,250,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |